Anthony Kirck
Comptroller/Controller/Auditor en OPTINOSE, INC. .
Fortuna: 154 833 $ al 31/05/2024
Cargos activos de Anthony Kirck
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01/11/2021 | - |
Historial de carrera de Anthony Kirck
Antiguos cargos conocidos de Anthony Kirck.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01/02/2020 | 01/11/2021 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01/06/2017 | 01/02/2020 |
Formación de Anthony Kirck.
| Albright College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Irlanda | 2 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Anthony Kirck
- Experiencia
